drugset / Trial / NCT06235905
Open-Label of SPN-820 in Adults With Major Depressive Disorder
NaSingle-groupOpen-labelTreatment
Summary
This study will evaluate of the efficacy and safety of SPN-820 in Adults With Major Depressive Disorder (MDD)
Timeline
- Start
- 2024-02-15
- Primary completion
- 2024-08-18
- Completion
- 2024-08-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NV-5138 | Small molecule | 2400 mg | Oral |